Characterization of the humoral and cellular immune responses against hepatitis C virus core induced by DNA-based

G J Hu1, R Y Wang, D S Han

  • 1Department of Transfusion Medicine, Warren G. Magnuson Clinical Center, National Institutes of Health, Bethesda, MD 20892-1184, USA.

Vaccine
|August 26, 1999
PubMed

Insights

DNA-based immunization shows promise for Hepatitis C Virus (HCV) infection. Vaccination with HCV-core DNA sequences effectively induced humoral and cellular immune responses, suggesting a potential new vaccine strategy.

Area of Science:

  • Immunology
  • Virology
  • Vaccine Development

Background:

  • Hepatitis C Virus (HCV) is a major cause of posttransfusion hepatitis, leading to chronic liver disease, cirrhosis, and hepatocellular carcinoma.
  • Current therapies for HCV are minimally effective, and no vaccine is currently available.
  • DNA-based immunization presents a potential prophylactic and therapeutic strategy for HCV infection.

Purpose of the Study:

  • To evaluate the efficacy of DNA-based immunization with a Hepatitis C Virus (HCV) recombinant plasmid in inducing humoral and cellular immune responses.
  • To investigate the potential of boosting with recombinant HCV-core protein to enhance immune responses.
  • To characterize the nature of the immune response, including T helper cell priming and cytotoxic T lymphocyte (CTL) activity.

Main Methods:

  • BALB/c mice were intramuscularly inoculated with an HCV recombinant plasmid (pCI-HCV-C).
  • Mice were boosted with recombinant HCV-core protein (cp1-10).
  • Humoral responses (IgM, IgG), spleen cell proliferation, T cell phenotypes (CD4+, CD8+), and cytotoxic T lymphocyte (CTL) activity were assessed using methods including Western-blotting, proliferation blocking assays, and 51Cr-release assays.

Main Results:

  • pCI-HCV-C immunization induced significant IgM but not IgG antibodies.
  • Boosting with cp1-10 rapidly increased anticore IgG levels and spleen cell proliferation.
  • Specific T helper cell priming (CD4+ CD8-) and MHC class I-restricted CTL responses (CD4- CD8+) against HCV-core were demonstrated, with three CTL epitopes identified.

Conclusions:

  • DNA-based vaccination with HCV-core derived DNA sequences is effective in inducing both humoral and cellular immune responses.
  • This approach holds potential as a vaccination strategy for Hepatitis C Virus infection.
  • The study highlights the importance of boosting with core protein to achieve robust IgG responses and CTL activity.

Related Concept Videos

Cell-mediated Immune Responses01:40

Cell-mediated Immune Responses

Overview
Humoral Immune Responses01:36

Humoral Immune Responses

Overview
Cytotoxic T Cells-mediated Immune Response01:27

Cytotoxic T Cells-mediated Immune Response

Cytotoxic T cells are a vital component of the immune system. They have the remarkable ability to identify and target antigens on infected or abnormal cells. These antigens often originate from intracellular pathogens such as viruses or abnormal proteins cancer cells produce.
Immunological surveillance is the ability of immune cells to monitor and eliminate infected cells with intracellular pathogens, neoplastically transformed cells, and cells with non-self antigens. Cytotoxic T cells and NK...
Immune Response Against Viral Pathogens01:29

Immune Response Against Viral Pathogens

The immune system's response to viral infections is a complex and coordinated process involving natural killer (NK) cells, T cell-mediated responses, and antibody-mediated responses.
NK Cells
NK cells are a crucial part of our innate immune system, acting as the first line of defense against viral infections. These cells can recognize and kill infected cells without prior exposure to the virus, effectively slowing down the spread of infection. Additionally, NK cells produce proinflammatory...
Hepatitis01:25

Hepatitis

Hepatitis is an inflammatory condition of the liver most commonly caused by hepatotropic viruses (A–E), though non-infectious causes such as alcohol and drugs also exist.Hepatitis AHepatitis A virus (HAV) is a non-enveloped RNA virus of the Picornaviridae family. It is primarily transmitted via the fecal-oral route, typically through ingestion of contaminated food or water. After ingestion, HAV enters the bloodstream through the oropharynx or intestinal epithelium and reaches the liver. The...
Viral Hepatitis I: Introduction01:28

Viral Hepatitis I: Introduction

Viral hepatitis is an inflammatory condition of the liver caused by infection with hepatotropic viruses, most commonly hepatitis A, B, C, D, and E. Despite variations in structure and transmission, all viruses mentioned infect hepatocytes and provoke immune responses that can hinder liver function. Additionally, some non-hepatotropic viruses can also lead to hepatic inflammation.Hepatitis A VirusHepatitis A virus (HAV) is transmitted through the fecal–oral route, typically by ingestion of food...